Daniel Wallerstorfer, PhD
Molecular biologist directing the science behind genetics-based testing and DNA-matched supplement protocols, built on two decades running a genetics lab
At a glance
- Languages
- English, German
Practice
About
Wallerstorfer is an Austrian molecular biologist who studied at the University of Manchester and finished a PhD in biotechnology at 25, with research spanning recombinant protein expression, RNA interference, and epigenetics. In 2009 he returned to Salzburg and founded Novogenia, a preventive genetic testing laboratory, securing the Austrian license for medical genetic tests that same year. Nutrigenetics (how genetic variation interacts with diet) has been his subject ever since. He joined 10X Health System as Chief Scientific Officer in 2025, directing the science behind its genetic testing and DNA-matched supplement formulation.
Approach
Signature approach
He works the translation problem: a genome read once, then turned into something usable. That means a micronutrient formula dosed to a person's own variants, a nutrition and weight strategy matched to how their body handles fat, carbohydrate, and exercise. The design principle he built Novogenia around is vertical control: laboratory, supplement manufacturing, and interpretation software in one building, so a saliva sample becomes a finished product without changing hands.
What sets them apart
- He runs the laboratory, not just an advisory seat. Founder and CEO of Novogenia, the Austrian genetics lab he took public on the Munich Stock Exchange in 2021 and scaled to 275,000 PCR samples a day at the pandemic peak.
- Written for a general reader, not a journal. Unlock Your Genes for Precision Health (2025) follows the German original Die Macht unserer Gene (Lübbe Verlag, 2021), alongside a 21-episode podcast on applied genetics.
- EY Entrepreneur of the Year, Austria (2021) in the innovation and high-tech category.
Focus
Specialties
Who they see
Training
Education
- PhD, BiotechnologyUniversity of Manchester (2009)
- BSc, Molecular BiologyUniversity of Manchester (2006)
Protocols
- Nutrigenetic snp panels
- Dna Matched micronutrient formulation
- Automated high Throughput genotyping
- Deep genome ai genome interpretation
Published work
Books
- 2025
- Lübbe Verlag, 2021
Publications
- Frontiers in Pediatrics, 2021
- Disaster Medicine and Public Health Preparedness, 2023
- COVID, 2021
Elsewhere
Media and talks
- PharmaBoardroom
- Unlock Your Genes
Collaboration
- Novogenia GmbHFounder and CEO of the Austrian genetics laboratory in Eugendorf; its listed parent group has disclosed a 10-year contract supplying genetic test kits and associated evaluations, plus nutritional supplements, for products sold under the 10X Health brand
- Novogenia AGCEO of the Munich Stock Exchange-listed biotech group he took public in 2021, spanning 13 founded and acquired companies
- REVIVChief Scientific Officer of the IV-therapy and wellness brand, in which Novogenia AG holds a minority investment
- GenopediaOpen-access human genetics database of genes, variants, traits and drug-gene interactions, funded and developed by Novogenia
- Medical University of GrazCo-supervised a 2021 master's thesis on applying personal genetic information to weight loss, alongside Ao.Univ.-Prof. Erwin Petek
Verification
- Profile updated
- Credentials checked
- Affiliations verified
Primary sourcehttps://www.10xhealthsystem.com/leadership
Where a detail is missing, it means we have not verified it—not that the answer is no. Directory listings are for informational purposes only. Inclusion does not constitute endorsement. Verify credentials and qualifications independently.